Literature DB >> 15086386

High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background.

M Okamoto1, M Takagi, M Kutsuna, Y Hara, M Nishihara, M C Zhang, T Matsuda, M Sakanaka, S Okamoto, M Nose, Y Ohashi.   

Abstract

MRL/Mp mice bearing the Fas deletion mutant gene, lpr (MRL/lpr), spontaneously develop polyarthritis, sialoadenitis and dacryoadenitis, resembling rheumatoid arthritis (RA), and also corneal involvement such as keratopathy and scleritis, which is a major complication in RA patients. In this study, we found that the expression levels of IL-1beta and MMP-1 mRNAs in cornea were high in both MRL/lpr and MRL/Mp-+/+ strains of mice at an age younger than when they develop any inflammatory lesions. This was not true of other inbred strains, even those bearing the lpr gene, and also not of (NZB x NZW) F1 lupus mice. There was no significant difference in the expression of IL-1alpha and TGFbeta in cornea in these strains. Using crosses between MRL/lpr and C3H/HeJ-lpr/lpr (C3H/lpr) mice, at least the expression of IL-1beta was found to be under the control of the MRL genetic background, likely with a recessive mode of inheritance. Considering that IL-1beta in cornea was detected particularly in the epithelial layer, the high expression of IL-1beta in cornea is most likely involved in the genetic predisposition for corneal involvement and possibly also for arthritis in an MRL strain of mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086386      PMCID: PMC1809023          DOI: 10.1111/j.1365-2249.2004.02428.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Genetic dissection of the complex pathological manifestations of collagen disease in MRL/lpr mice.

Authors:  S Nakatsuru; M Terada; M Nishihara; J Kamogawa; T Miyazaki; W M Qu; K Morimoto; C Yazawa; H Ogasawara; Y Abe; K Fukui; G Ichien; M R Ito; S Mori; Y Nakamura; M Nose
Journal:  Pathol Int       Date:  1999-11       Impact factor: 2.534

2.  Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

Authors:  D D McGavin; J Williamson; J V Forrester; W S Foulds; W W Buchanan; W C Dick; P Lee; R N MacSween; K Whaley
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

3.  Ulceration of the cornea in rheumatoid arthritis.

Authors:  M I Jayson; D L Easty
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

4.  Regulation of stromal cell collagenase production in adult rabbit cornea: in vitro stimulation and inhibition by epithelial cell products.

Authors:  B Johnson-Wint
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Scleritis and episcleritis.

Authors:  P G Watson; S S Hayreh
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

Review 6.  The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.

Authors:  M E Stern; R W Beuerman; R I Fox; J Gao; A K Mircheff; S C Pflugfelder
Journal:  Cornea       Date:  1998-11       Impact factor: 2.651

7.  Corneal ulceration and perforation associated with Sjögren's syndrome.

Authors:  R R Pfister; G E Murphy
Journal:  Arch Ophthalmol       Date:  1980-01

8.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

Authors:  S B Mizel; J M Dayer; S M Krane; S E Mergenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Interleukin 1 stimulation of collagenase production by cultured fibroblasts.

Authors:  A E Postlethwaite; L B Lachman; C L Mainardi; A H Kang
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  5 in total

1.  Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation.

Authors:  Marko Pastak; Veronika Kleff; Daniel R Saban; Marta Czugala; Klaus-Peter Steuhl; Süleyman Ergün; Bernhard B Singer; Thomas A Fuchsluger
Journal:  Hum Gene Ther       Date:  2017-10-06       Impact factor: 5.695

2.  The expression of matrix metalloproteinases and their inhibitors in corneal fibroblasts by alarmins from necrotic corneal epithelial cells.

Authors:  Akira Iwatake; Akira Murakami; Nobuyuki Ebihara
Journal:  Jpn J Ophthalmol       Date:  2017-11-01       Impact factor: 2.447

3.  Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea.

Authors:  W Michael Stapleton; Shyam S Chaurasia; Fabricio W Medeiros; Rajiv R Mohan; Sunilima Sinha; Steven E Wilson
Journal:  Exp Eye Res       Date:  2008-02-13       Impact factor: 3.467

4.  Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice.

Authors:  Julie Swenson; Selen Olgun; Ali Radjavi; Taranjit Kaur; Christopher M Reilly
Journal:  Eur J Pharmacol       Date:  2007-04-06       Impact factor: 4.432

5.  Effect of Different Antibiotic Chemotherapies on Pseudomonas aeruginosa Infection In Vitro of Primary Human Corneal Fibroblast Cells.

Authors:  Maria Del Mar Cendra; Myron Christodoulides; Parwez Hossain
Journal:  Front Microbiol       Date:  2017-08-22       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.